Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373459 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
Novel 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives have been prepared and their synthesis described herein. In vitro affinities for δ-, μ-, and κ-opioid receptors are reported. Evaluation of some representative compounds from this series in the mouse neonatal ultrasonic vocalization test and the mouse tail suspension test revealed anxiolytic- and antidepressant-like effects, respectively, upon subcutaneous administration.
Graphical abstractSelective δ-opioid agonists based on the 4-phenyl-4-[1H-imidazol-2-yl]-piperidine scaffold are reported. Compound 3h has shown anxiolytic-/antidepressant-like effects in two mouse animal models.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Andrés A. Trabanco, Nancy Aerts, Rosa M. Alvarez, José I. Andrés, Inge Boeckx, Javier Fernández, Antonio Gómez, Frans E. Janssens, Joseph E. Leenaerts, Ana I. De Lucas, Encarna Matesanz, Thomas Steckler, Shirley Pullan,